SKYE vs VLO · $25.0M cap vs P/E 18, rev $76.86B
Skye Bioscience, Inc. Common Stock (SKYE) versus Valero Energy Corporation (VLO) — a side-by-side from cached financials, not a winner call.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Valero Energy Corporation (VLO) is a oil & gas refining & marketing company listed on NYSE.
SKYE does not have a complete income-statement cache yet.
Latest reported VLO revenue for 2026-06-30 was $76.86B. Net income was $4.98B. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
SKYE currently screens at market cap $25.0M. VLO currently screens at market cap $71.20B and trailing P/E 17.5.
Not investment advice. Open the SKYE and VLO stock pages for the full models.
Not investment advice.